Aurobindo Pharma Gets USFDA Approval for Generic Cancer Drug
December 5, 2024 16:30
Aurobindo Pharma's subsidiary, Eugia Pharma Specialities, has received USFDA approval to market Pazopanib Tablets (200 mg) in the US. The drug is therapeutically equivalent to Novartis' Votrient...